Statements (49)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
medical device
|
| gptkbp:approves |
gptkb:FDA
|
| gptkbp:compatibleWith |
smartphone applications
|
| gptkbp:designedFor |
drug delivery
|
| gptkbp:enables |
customizable settings
|
| gptkbp:enhances |
patient compliance
|
| gptkbp:features |
user-friendly interface
continuous glucose monitoring |
| gptkbp:has |
battery life
|
| https://www.w3.org/2000/01/rdf-schema#label |
SmartPump®
|
| gptkbp:includes |
cartridge system
|
| gptkbp:integratesWith |
CGM_systems
|
| gptkbp:isAttendedBy |
user manual
|
| gptkbp:isAvailableIn |
multiple countries
various models prescription |
| gptkbp:isCompatibleWith |
various insulin types
|
| gptkbp:isDesignedFor |
type 2 diabetes
type 1 diabetes improve glycemic control |
| gptkbp:isEnhancedBy |
software updates
|
| gptkbp:isLinkedTo |
better health outcomes
|
| gptkbp:isMarketedAs |
advanced insulin delivery system
|
| gptkbp:isPartOf |
patient-centered care
diabetes management solutions Medtronic's_diabetes_portfolio Medtronic's_product_line |
| gptkbp:isPromotedBy |
healthcare_providers
|
| gptkbp:isPromotedThrough |
patient education programs
|
| gptkbp:isRecognizedBy |
diabetes associations
|
| gptkbp:isRecognizedFor |
innovation in diabetes care
|
| gptkbp:isSubjectTo |
regulatory standards
|
| gptkbp:isSupportedBy |
clinical studies
insurance plans healthcare_professionals |
| gptkbp:isTestedFor |
safety and efficacy
|
| gptkbp:isUsedBy |
diabetes patients
|
| gptkbp:isUsedIn |
hospitals
home care settings |
| gptkbp:isUtilizedIn |
clinical trials
clinical practice |
| gptkbp:offers |
personalized therapy
|
| gptkbp:producedBy |
gptkb:Medtronic
|
| gptkbp:provides |
real-time data
automated insulin delivery |
| gptkbp:reduces |
hypoglycemia risk
|
| gptkbp:requires |
regular maintenance
|
| gptkbp:supports |
remote monitoring
|
| gptkbp:uses |
insulin
|